Concord Biotech Limited (CONCORDBIO.BO)
INR 2153.4
(-1.05%)
INR 2153.4
(-1.05%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.65 Billion INR | 14.68% |
| 2022 | 3.83 Billion INR | 27.99% |
| 2021 | 2.97 Billion INR | -12.08% |
| 2020 | 3.41 Billion INR | 49.73% |
| 2019 | 2.35 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 812.78 Million INR | -36.88% |
| 2023 FY | - INR | 14.68% |
| 2023 Q3 | 1.17 Billion INR | -5.41% |
| 2023 Q2 | 1.23 Billion INR | 71.64% |
| 2023 Q4 | 1.34 Billion INR | 14.64% |
| 2023 Q1 | 721.52 Million INR | -48.18% |
| 2022 Q2 | 434.69 Million INR | -31.29% |
| 2022 FY | - INR | 27.99% |
| 2022 Q4 | 1.39 Billion INR | 16.8% |
| 2022 Q3 | 1.19 Billion INR | 174.26% |
| 2022 Q1 | 632.62 Million INR | 0.0% |
| 2021 FY | - INR | -12.08% |
| 2020 FY | - INR | 49.73% |
| 2019 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | -45920.466% |
| Biocon Limited | 41.52 Billion INR | 88.78% |
| Blue Jet Healthcare Limited | 2.29 Billion INR | -103.251% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | -51.674% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | -1673.67% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | -3160720.07% |
| Lyka Labs Limited | 167.58 Million INR | -2680.082% |
| Panacea Biotec Limited | -200.6 Million INR | 2422.588% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 189460.158% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | -1233.423% |
| Supriya Lifescience Limited | 1.83 Billion INR | -153.797% |
| Syngene International Limited | 10.84 Billion INR | 57.047% |
| TAKE Solutions Limited | -1.05 Billion INR | 543.37% |
| Titan Biotech Limited | 360.29 Million INR | -1193.135% |
| Transgene Biotek Limited | -4.33 Million INR | 107477.552% |
| Vanta Bioscience Limited | 14.19 Million INR | -32731.457% |